Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$912M |
| 2 |
Pinduoduo
PDD
|
+$727M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$584M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$501M |
| 5 |
GE Aerospace
GE
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.45B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.3B |
| 3 |
Apple
AAPL
|
+$1.26B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$795M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$650M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.48% |
| 2 | Financials | 8.47% |
| 3 | Consumer Discretionary | 7.62% |
| 4 | Healthcare | 7.22% |
| 5 | Industrials | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GORV
5176
DELISTED
Lazydays
GORV
| $98.5K | ﹤0.01% |
814
-893
| -52% | -$124K |
|
|
UROY
5177
Uranium Royalty Corp
UROY
$1.36B
| $97.2K | ﹤0.01% |
+40,671
| New | +$116K |
|
5178
Polestar Automotive Holding UK
PSNY
$2.13B
| $96.8K | ﹤0.01% |
2,094
-515
| -20% | -$27.9K |
|
|
NB
5179
NioCorp Developments
NB
$731M
| $93.5K | ﹤0.01% |
34,387
+95
| +0.3% | +$267 |
|
5180
Marchex
MCHX
$80.6M
| $93.1K | ﹤0.01% |
67,929
+2
| +0% | +$3 |
|
5181
Torrid Holdings
CURV
$258M
| $92.4K | ﹤0.01% |
18,925
+479
| +3% | +$2.36K |
|
5182
AN2 Therapeutics
ANTX
$210M
| $92.2K | ﹤0.01% |
28,370
+14,324
| +102% | +$156K |
|
5183
OppFi
OPFI
$836M
| $92.1K | ﹤0.01% |
36,846
+11,497
| +45% | +$39.1K |
|
|
NEXN
5184
Nexxen International
NEXN
$583M
| $92K | ﹤0.01% |
17,622
-1,459
| -8% | -$7.35K |
|
|
DNMR
5185
DELISTED
Danimer Scientific, Inc.
DNMR
| $91.9K | ﹤0.01% |
2,108
-9,263
| -81% | -$384K |
|
|
MAPS
5186
DELISTED
WM TECHNOLOGY INC A
MAPS
| $91.3K | ﹤0.01% |
68,650
| – | – |
|
5187
Village Farms International
VFF
$238M
| $90.8K | ﹤0.01% |
73,225
| – | – |
|
|
RGF
5188
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
| $89.5K | ﹤0.01% |
+20,659
| New | +$262K |
|
|
ONCY
5189
Oncolytics Biotech
ONCY
$95.1M
| $88.6K | ﹤0.01% |
+83,598
| New | +$93.4K |
|
5190
Actinium Pharmaceuticals
ATNM
$23.5M
| $87.3K | ﹤0.01% |
11,147
-4,333
| -28% | -$27.9K |
|
5191
Cue Biopharma
CUE
$112M
| $86.3K | ﹤0.01% |
1,521
-423
| -22% | -$29.8K |
|
|
EFTRW
5192
DELISTED
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
| $85.2K | ﹤0.01% |
630,539
| – | – |
|
5193
Oportun Financial
OPRT
$278M
| $85.1K | ﹤0.01% |
35,040
-82,590
| -70% | -$298K |
|
|
API
5194
Agora
API
$349M
| $84.8K | ﹤0.01% |
33,799
| – | – |
|
5195
Genelux
GNLX
$113M
| $84.8K | ﹤0.01% |
+13,186
| New | +$120K |
|
5196
Babcock & Wilcox
BW
$1.42B
| $84.6K | ﹤0.01% |
74,875
-166,332
| -69% | -$206K |
|
|
EXAI
5197
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $81.8K | ﹤0.01% |
14,299
+3,670
| +35% | +$22.8K |
|
5198
BlackSky Technology
BKSY
$1.03B
| $81.1K | ﹤0.01% |
7,455
-2,389
| -24% | -$26.2K |
|
5199
ProKidney
PROK
$343M
| $80.8K | ﹤0.01% |
49,264
+11,631
| +31% | +$17.1K |
|
|
OMGA
5200
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $80.5K | ﹤0.01% |
22,068
+9,090
| +70% | +$34.9K |
|
Similar funds
Goldman Sachs's Q1 2024 Portfolio in Review
As of Q1 2024, Goldman Sachs held 6,050 positions worth $564B, up 4% from $543B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs withdrew a net $23.2B in Q1 2024, closing 529 positions and reducing 2,527 holdings. Its most notable exit was Cooper Companies, an estimated $173M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Goldman Sachs opened a new position in State Street SPDR Portfolio Long Term Treasury ETF worth $195M.
- Goldman Sachs's largest Q1 2024 buy was State Street SPDR Portfolio Long Term Treasury ETF: 6,982,911 shares worth $195M.
- Goldman Sachs added most to iShares Core S&P 500 ETF in Q1 2024, an estimated $912M increase.
- Goldman Sachs's biggest Q1 2024 reduction was Microsoft, cutting an estimated $1.45B.
- Goldman Sachs fully exited Cooper Companies in Q1 2024, selling an estimated $173M.
- Goldman Sachs's ten largest holdings make up 19% of its $564B portfolio in Q1 2024.
- Goldman Sachs opened 470 new positions and closed 529 in Q1 2024.
- Goldman Sachs's portfolio value rose 4% quarter-over-quarter to $564B.
Based on Goldman Sachs's 13F filing for Q1 2024, filed 15 May 2024.